Furthermore, previous mechanistic studies have shown that JUNB overexpression regulates the mitochondrial apoptosis pathway, mediating resistance to FasL and TRAIL-induced cell death, and thus tumor resistance to immunotherapy (77). Here, JUNB is linked to neoplasm.